Key facts
- Viomerse’s last known valuation is $25.0M (Sep 2023).
- It has raised $6.8M across 1 recorded rounds; the latest was Seed Round ($350K) in Jun 2025.
- Notable investors include Small Business Innovation Research and Small Business Technology Transfer Programs.
- Viomerse has filed 2 Form Ds with the SEC, most recently Jul 2025 ($350K sold to 2 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Viomerse
Funding rounds
1 roundsAbout Viomerse
Developer of a surgical education platform designed to give surgeons immersive training without risks to patients. The company's models offer high-fidelity training phantoms, central line placement, cholecystectomy, and intermediate skills training, both physical classes and virtual, enabling surgeons to train more efficiently.
- Sector
- Healthcare
- HQ
- Pittsford, NY, United States
- Founded
- 2016
- Employees
- 17
- Website
- viomerse.com/
- Ownership
- Privately Held (backing)
Viomerse doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Viomerse shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Viomerse in its N-PORT filings yet. We sweep new filings monthly.